Literature DB >> 2233632

Estimated prevalence of Alzheimer's disease in the United States.

D A Evans1.   

Abstract

Although awareness of Alzheimer's disease has increased strikingly among professional and lay audiences, precise means do not exist to calculate how many Americans the disease affects. Projecting data from a cohort of 32,000 individuals in a defined community in the United States, however, suggests that there were 2.88 million persons aged 65 or older with probable Alzheimer's disease in 1980. Using U.S. Census Bureau middle series projections yields an estimated total of 10.3 million persons with the disease for the year 2050. Limitations on these estimates notwithstanding, the projections indicate that more studies are needed to identify the etiology of Alzheimer's disease, its incidence, and the future costs of relevant institutional and community care.

Entities:  

Mesh:

Year:  1990        PMID: 2233632

Source DB:  PubMed          Journal:  Milbank Q        ISSN: 0887-378X            Impact factor:   4.911


  49 in total

Review 1.  Dementia in the elderly: the "silent epidemic" no more.

Authors:  E B Larson
Journal:  Trans Am Clin Climatol Assoc       Date:  2001

Review 2.  The cost of Alzheimer's disease. Will drug treatment ease the burden?

Authors:  W Max
Journal:  Pharmacoeconomics       Date:  1996-01       Impact factor: 4.981

3.  Projections of Alzheimer's disease in the United States and the public health impact of delaying disease onset.

Authors:  R Brookmeyer; S Gray; C Kawas
Journal:  Am J Public Health       Date:  1998-09       Impact factor: 9.308

4.  High normal plasma triglycerides are associated with preserved cognitive function in Chinese oldest-old.

Authors:  Zhao-Xue Yin; Xiao-Ming Shi; Virginia B Kraus; Simon M Fitzgerald; Han-Zhu Qian; Jian-Wei Xu; Yi Zhai; Melanie D Sereny; Yi Zeng
Journal:  Age Ageing       Date:  2012-03-23       Impact factor: 10.668

5.  The measurement of everyday cognition: development and validation of a short form of the Everyday Cognition scales.

Authors:  Sarah Tomaszewski Farias; Dan Mungas; Danielle J Harvey; Amanda Simmons; Bruce R Reed; Charles Decarli
Journal:  Alzheimers Dement       Date:  2011-11       Impact factor: 21.566

6.  Marital quality in the context of mild cognitive impairment.

Authors:  Linda Garand; Mary Amanda Dew; Bridget Urda; Jennifer Hagerty Lingler; Steven T Dekosky; Charles F Reynolds
Journal:  West J Nurs Res       Date:  2007-12       Impact factor: 1.967

7.  Prevalence of cognitive impairment without dementia in the United States.

Authors:  Brenda L Plassman; Kenneth M Langa; Gwenith G Fisher; Steven G Heeringa; David R Weir; Mary Beth Ofstedal; James R Burke; Michael D Hurd; Guy G Potter; Willard L Rodgers; David C Steffens; John J McArdle; Robert J Willis; Robert B Wallace
Journal:  Ann Intern Med       Date:  2008-03-18       Impact factor: 25.391

8.  Caloric restriction attenuates amyloid deposition in middle-aged dtg APP/PS1 mice.

Authors:  Peter R Mouton; Mark E Chachich; Christopher Quigley; Edward Spangler; Donald K Ingram
Journal:  Neurosci Lett       Date:  2009-08-20       Impact factor: 3.046

Review 9.  Trends in the molecular pathogenesis and clinical therapeutics of common neurodegenerative disorders.

Authors:  Yahya E Choonara; Viness Pillay; Lisa C Du Toit; Girish Modi; Dinesh Naidoo; Valence M K Ndesendo; Sibongile R Sibambo
Journal:  Int J Mol Sci       Date:  2009-06-03       Impact factor: 6.208

Review 10.  Economic considerations in the management of Alzheimer's disease.

Authors:  Carolyn W Zhu; Mary Sano
Journal:  Clin Interv Aging       Date:  2006       Impact factor: 4.458

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.